- Report
- May 2025
- 181 Pages
Global
From €3142EUR$3,545USD£2,732GBP
€3491EUR$3,939USD£3,035GBP
- Report
- July 2024
- 150 Pages
Global
From €5274EUR$5,950USD£4,585GBP
- Report
- February 2025
- 200 Pages
Global
From €3980EUR$4,490USD£3,460GBP
- Report
- July 2025
- 271 Pages
Global
From €5185EUR$5,850USD£4,508GBP
- Report
- February 2025
- 184 Pages
Global
From €3390EUR$3,825USD£2,948GBP
€3989EUR$4,500USD£3,468GBP
- Report
- November 2024
- 239 Pages
Global
From €3701EUR$4,175USD£3,217GBP
- Report
- May 2025
- 188 Pages
Global
From €3142EUR$3,545USD£2,732GBP
€3491EUR$3,939USD£3,035GBP
- Report
- May 2025
- 183 Pages
Global
From €3142EUR$3,545USD£2,732GBP
€3491EUR$3,939USD£3,035GBP
- Report
- May 2025
- 195 Pages
Global
From €3142EUR$3,545USD£2,732GBP
€3491EUR$3,939USD£3,035GBP
- Report
- May 2025
- 193 Pages
Global
From €3142EUR$3,545USD£2,732GBP
€3491EUR$3,939USD£3,035GBP
- Report
- May 2025
- 195 Pages
Global
From €3142EUR$3,545USD£2,732GBP
€3491EUR$3,939USD£3,035GBP
- Report
- May 2025
- 191 Pages
Global
From €3142EUR$3,545USD£2,732GBP
€3491EUR$3,939USD£3,035GBP
- Report
- May 2025
- 187 Pages
Global
From €3142EUR$3,545USD£2,732GBP
€3491EUR$3,939USD£3,035GBP
- Report
- May 2025
- 182 Pages
Global
From €3142EUR$3,545USD£2,732GBP
€3491EUR$3,939USD£3,035GBP
- Report
- May 2025
- 186 Pages
Global
From €3142EUR$3,545USD£2,732GBP
€3491EUR$3,939USD£3,035GBP
- Report
- May 2025
- 189 Pages
Global
From €3142EUR$3,545USD£2,732GBP
€3491EUR$3,939USD£3,035GBP
- Report
- August 2024
- 100 Pages
Global
From €5274EUR$5,950USD£4,585GBP
- Report
- April 2025
- 175 Pages
Global
From €3980EUR$4,490USD£3,460GBP
- Report
- March 2025
- 200 Pages
Global
From €3980EUR$4,490USD£3,460GBP
- Report
- March 2025
- 200 Pages
Global
From €3980EUR$4,490USD£3,460GBP

The Conjugate Vaccine market is a subset of the Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Conjugate Vaccines are a type of vaccine that combines a polysaccharide antigen with a protein carrier, which helps the body to recognize the antigen and mount an immune response. These vaccines are used to protect against a variety of bacterial infections, including meningitis, pneumonia, and sepsis.
Conjugate Vaccines are typically administered to infants and young children, as their immune systems are not yet fully developed and are more susceptible to certain infections. In addition, these vaccines are often used in combination with other vaccines to provide broader protection against multiple diseases.
Notable companies in the Conjugate Vaccine market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Novartis. Show Less Read more